Strategic Expansion Recent acquisition of Cencora assets and expansion of patient access platform indicate growing scale and capabilities. This presents upsell opportunities for broader enterprise deployment, integration with larger pharma and provider networks, and cross-sell of enhanced routing for prior authorization and enrollment processes.

Platform Upgrades March 2026 launch of next-generation patient access platform signals modernization and additional features. Sales conversations can emphasize containerization of workflows, improved data insights, and seamless integration with existing EHRs and PBMs to win new clients seeking state-of-the-art efficiency.

Leadership Signals Recent appointments of President/CSO and CFO, plus new CCO in 2025, suggest a focus on strategic growth, governance, and commercial expansion. Leverage with prospects by highlighting strong leadership, clear roadmaps, and disciplined go-to-market strategies to build trust.

Partnership Momentum Strategic engagement with Syneos Health and active industry event participation indicate external validation and network effects. Use referenceable partnerships to position PX Connect as a trusted hub for patient access, enabling co-sell opportunities with large biopharma services organizations.

Growth Readiness Revenue in the reported range and a compact, high-impact tech stack common in services firms. Target mid-market and growing specialty pharma/biotech companies seeking scalable patient access and prior authorization automation, offering rapid ROI and low friction deployment.